The ability to express transgenes selectively within the lung will greatly facilitate the development of gene therapy for a variety ofhuman diseases. We have demonstrated that aerosol administration of a chloramphenicol acetltransferase (CAT) expression plasmid complexed to cationic liposomes produces high-level, lung-specific CAT gene expression in mice in vivo. Significant levels of CAT activity are seen in the lungs for at least 21 days following aerosolization. were each diluted to 8 ml with water and mixed. Equal volumes were then placed into two Acorn I nebulizers (Marquest, Englewood, CO), the animals were loaded into an Intox small-animal exposure chamber (Albuquerque), and an air flow rate of 4 liters/min was used to generate the aerosol. Approximately 90 min were required to aerosolize this volume. The animals were removed from the chamber for 1-2 hr and then the above procedure was repeated.
With the advent of molecular cloning techniques, an expanding array of genes with mutations responsible for important human diseases have been identified and isolated. To date, attempts to replace absent or mutated genes in human patients have relied on ex vivo techniques (1) , since methods for safe and effective in vivo gene delivery are not currently available. Retroviruses (2) , adenoviruses (3, 4) , and liposomes (5) have been used in animal model studies in attempts to increase the efficiency of gene transfer. DNA has been introduced into animals by intratracheal (3, 4, 6, 7) , intravenous (7, 8) , intraperitoneal (9, 10) , intramuscular (11, 12) , and intraarterial (13) injections. The lung is a particularly attractive organ for in vivo gene therapy because it is directly accessible via the airway. The recent correction of defective chloride channel regulation in cystic fibrosis airway epithelial cells following ex vivo introduction of the cystic fibrosis transmembrane conductance regulator gene (14) suggests an obvious target for this type of therapy. Expression of introduced genes, either complexed to cationic liposomes (6, 7) or packaged in adenoviral vectors (3, 4) , has been demonstrated in the lungs of rodents after intratracheal instillation. However, intratracheal injection is invasive and produces a nonuniform distribution of the instilled material (15) . In contrast, aerosol delivery is noninvasive, results in deeper penetration of material into the lungs, and can deposit aerosolized material throughout the airways and alveoli of healthy individuals (16) . Furthermore, aerosol administration has delivered biologically active macromolecules to the lungs of rodents (17, 18) and humans (19, 20) . We 7 .5/5 mM EDTA plus the protease inhibitors aprotinin, E-64, and leupeptin (Boehringer Mannheim), for liver, heart, and kidneys. These inhibitors prevent degradation of acetylated chloramphenicol species generated during the assay, thereby allowing optimal detection of CAT Abbreviations: CAT, chloramphenicol acetyltransferase; CMV, cytomegalovirus; DOPE, dioleoyl phosphatidylethanolamine;
§To whom reprint requests should be addressed.
11277
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
expression (data not shown). After homogenization, cells were lysed by three freeze/thaw cycles, and the lysate was heated (650C for 10 min) and centrifuged (16, (Fig. 4 A and D) and x250 (Fig. 4 B, C , E, and F).
RESULTS AND DISCUSSION
Initially, mice were exposed either to an aerosol generated from a solution containing 12 mg of a CMV-CAT expression plasmid alone or to an aerosol generated from a solution containing 12 mg of CMV-CAT complexed to 24 Amol of DOTMA/DOPE (1:1) liposomes. Aerosols were administered to animals after they were placed individually in noseout cones and inserted into an Intox small-animal exposure chamber. Mice showed no apparent ill effects or respiratory distress either during or after aerosol exposure. Fig. 1 shows the results of CAT assays from extracts of the lungs of mice sacrificed 72 hr after aerosol administration. Significant CAT gene expression was seen only in mice exposed to aerosolized DNA/liposome complexes. There was no CAT activity above background present in mice exposed to aerosolized DNA alone, demonstrating that the cationic liposome carrier was required for transfection. In addition, mice placed unrestrained in a 2-liter enclosed plastic box and exposed to DNA/liposome aerosols showed no CAT activity (data not shown).
We then investigated how long CAT protein was present in the lungs of mice and whether expression ofthe reporter gene was limited to the lungs. Despite inter-animal variation, high levels of CAT activity were present for at least 21 days following a single aerosol dose of DNA/liposome complexes ( Fig. 2A) . No CAT activity was detectable in extracts from the heart, spleen, kidneys, or liver of animals that showed high-level expression in the lungs (Fig. 28) , suggesting that transgene expression following aerosol delivery is restricted to the lungs. This is consistent with prior observations showing that penetration of very high molecular weight substances through the respiratory epithelium of normal animals is very limited (25) Immediately following aerosolization, the animals were sacrificed, their lungs were removed and homogenized, and rhodamine fluorescence was measured in a fluorimeter, as described (26) . The recovered fluorescence per animal was 0.06 ± 0.02% (mean + SD) of the total amount aerosolized.
This suggests that <10 pug out of the 12 mg of DNA aerosolized per experiment was actually deposited in the lung. In addition, there was no significant difference in lipid deposition between animals receiving liposomes alone and those receiving the DNA/liposome complexes (data not shown).
Since it was possible that a disruption of the complex could have occurred during nebulization, we also assessed the amount of CAT gene deposited during aerosolization (Fig. 3) . Immediately after aerosol delivery of DNA/liposome complexes, mice were sacrificed and total lung DNA was prepared. Southern blots were probed with 32P-labeled CAT probe. Labeled bands were scanned and demonstrated a <4-fold difference in plasmid deposition between animals in the same experiment (Fig. 3) . These results suggest that the mouse-to-mouse variation in CAT gene levels following aerosol delivery (up to 10-fold) is not only a function of the amount ofcomplex initially deposited in the lung but may also reflect differences in the site ofuptake, rate oflung clearance, and/or variation in the ability of different lung cell types to express the transgene.
To determine the types and percentage of lung cells that were transfected in vivo, lungs of mice sacrificed 72 hr after exposure to an aerosol containing DNA/liposome complexes were cryosectioned, probed with a polyclonal anti-CAT antibody, and counterstained to detect intracellular CAT protein (Fig. 4) (Fig. 4C) . Controls included replacement of the primary antibody with normal rabbit serum (Fig. 4D) and use of lung sections from untreated animals (Fig. 4 E and F are several potential advantages to using aerosolized cationic liposomes as an in vivo gene delivery system. First, cationic liposomes can mediate efficient transfection of nondividing cells (27, 28) . This is important because many airway epithelial cells are well differentiated and divide slowly or not at all (29) . Second, liposomes (including liposomes containing cationic lipids) are noninfectious and appear to be both well tolerated and nonimmunogenic in a variety of human clinical trials (30, 31) . However, the effects of repeated aerosol administration of DNA/liposome complexes into both normal and diseased lungs will need to be tested. Finally, it may be possible to achieve more precise intrapulmonary targeting by altering aerosol particle size to preferentially direct the aerosol to alveoli or proximal versus distal airways (15) 
